R&D Expenses

$278.84M

TTM · Period ending: Jun 30, 2026 · USD

CLDX R&D Expenses

Latest reported$278.84Mperiod endingJun 30, 2026

CLDX TTM R&D Expenses ($0.00 → $278.84M)

TTM R&D Expenses

High-resolution chart · PNG

CLDX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Celldex Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	278,840,000
Mar 31, 2026	265,487,000
Dec 31, 2025	245,100,000
Sep 30, 2025	215,861,000
Jun 30, 2025	198,193,000
Mar 31, 2025	182,887,000
Dec 31, 2024	161,159,000
Sep 30, 2024	145,465,000
Jun 30, 2024	134,737,000
Mar 31, 2024	122,099,000
Dec 31, 2023	118,011,000
Sep 30, 2023	110,484,000
Jun 30, 2023	97,521,000
Mar 31, 2023	92,000,000
Dec 31, 2022	82,258,000
Sep 30, 2022	74,037,000
Jun 30, 2022	69,522,000
Mar 31, 2022	61,147,000
Dec 31, 2021	56,811,000
Sep 30, 2021	70,558,000
Jun 30, 2021	64,209,000
Mar 31, 2021	65,058,000
Dec 31, 2020	64,033,000
Sep 30, 2020	45,947,000
Jun 30, 2020	46,340,000
Mar 31, 2020	43,216,000
Dec 31, 2019	42,672,000
Sep 30, 2019	43,540,000
Jun 30, 2019	44,357,000
Mar 31, 2019	55,724,000
Dec 31, 2018	66,448,000
Sep 30, 2018	78,705,000
Jun 30, 2018	88,702,000
Mar 31, 2018	92,253,000
Dec 31, 2017	96,171,000
Sep 30, 2017	97,265,000
Jun 30, 2017	100,359,000
Mar 31, 2017	101,071,000
Dec 31, 2016	102,725,000
Sep 30, 2016	102,067,000
Jun 30, 2016	101,714,000
Mar 31, 2016	102,493,000
Dec 31, 2015	100,171,000
Sep 30, 2015	103,297,000
Jun 30, 2015	104,826,000
Mar 31, 2015	102,436,000
Dec 31, 2014	104,381,000
Sep 30, 2014	95,159,000
Jun 30, 2014	89,391,000
Mar 31, 2014	80,381,000
Dec 31, 2013	67,401,000
Sep 30, 2013	63,345,000
Jun 30, 2013	54,697,000
Mar 31, 2013	50,721,000
Dec 31, 2012	47,400,000
Sep 30, 2012	43,476,000
Jun 30, 2012	40,301,000
Mar 31, 2012	36,356,000
Dec 31, 2011	32,440,000
Sep 30, 2011	29,358,000
Jun 30, 2011	27,979,000
Mar 31, 2011	28,066,000
Dec 31, 2010	27,651,000
Sep 30, 2010	23,349,000
Jun 30, 2010	23,375,000
Mar 31, 2010	23,921,000
Dec 31, 2009	26,168,941
Sep 30, 2009	31,332,777
Jun 30, 2009	30,717,836
Mar 31, 2009	30,527,502
Dec 31, 2008	26,328,335
Sep 30, 2008	22,836,481
Jun 30, 2008	20,667,897
Mar 31, 2008	18,023,860
Dec 31, 2007	13,545,172
Sep 30, 2007	14,270,656
Jun 30, 2007	14,229,501
Mar 31, 2007	13,725,771
Dec 31, 2006	18,066,392
Sep 30, 2006	16,239,277
Jun 30, 2006	15,414,291
Mar 31, 2006	14,381,384
Dec 31, 2005	14,063,295
Sep 30, 2005	15,299,944
Jun 30, 2005	14,514,410
Mar 31, 2005	14,451,218
Dec 31, 2004	13,873,800
Sep 30, 2004	11,772,100
Jun 30, 2004	11,476,400
Mar 31, 2004	10,782,000
Dec 31, 2003	10,021,300
Sep 30, 2003	10,685,300
Jun 30, 2003	11,598,400
Mar 31, 2003	12,991,400
Dec 31, 2002	14,708,500
Sep 30, 2002	18,344,300
Jun 30, 2002	20,554,200
Mar 31, 2002	21,928,300
Dec 31, 2001	21,495,400
Sep 30, 2001	18,751,800